EUPRAXIA PHARMACEUTICALS INC. (EPRX) Return on equity 2023–2025
EUPRAXIA PHARMACEUTICALS INC. (EPRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-47.0%FY2025 · since FY2023: -1273.4% → -47.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -47.0% | +29.3 pp |
| FY2024 | -76.3% | +1197.0 pp |
| FY2023 | -1273.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice